Effect of miR-630 expression on esophageal cancer cell invasion and migration

Background: Esophageal cancer (EC) is a common malignancy of the digestive tract, with high incidence. The objective of this study was to investigate the effect of miR-630 expression on esophageal cancer (EC) cell invasion and migration. Methods: The study group comprised 58 EC patients admitted to...

Full description

Bibliographic Details
Main Authors: Liao, K. (Author), Liu, X. (Author), Qiu, Y. (Author), Tan, W. (Author), Wu, W. (Author), Yang, K. (Author), Zhang, S. (Author)
Format: Article
Language:English
Published: John Wiley and Sons Inc 2021
Subjects:
Online Access:View Fulltext in Publisher
LEADER 04397nam a2200997Ia 4500
001 10.1002-jcla.23815
008 220427s2021 CNT 000 0 und d
020 |a 08878013 (ISSN) 
245 1 0 |a Effect of miR-630 expression on esophageal cancer cell invasion and migration 
260 0 |b John Wiley and Sons Inc  |c 2021 
856 |z View Fulltext in Publisher  |u https://doi.org/10.1002/jcla.23815 
520 3 |a Background: Esophageal cancer (EC) is a common malignancy of the digestive tract, with high incidence. The objective of this study was to investigate the effect of miR-630 expression on esophageal cancer (EC) cell invasion and migration. Methods: The study group comprised 58 EC patients admitted to our hospital from April 2014 to 2016, and the control group comprised 60 healthy people visiting the hospital during the same period. miR-630 levels in the peripheral blood of the two groups were compared, and the diagnostic value of miR-630 for EC was analyzed. EC cell lines were used to evaluate the influence of miR-630 expression on EC cell invasion and migration. Results: miR-630 expression was low in EC (p < 0.050). A receiver operating characteristic curve analysis showed that miR-630 expression had a good diagnostic value for EC (p < 0.050) and was associated with disease course, pathological stage, differentiation degree, tumor metastasis, and patient prognosis and survival (p < 0.05). The ROC curve analysis showed that when cutoff value was 5.38, the diagnostic sensitivity and specificity of miR-630 for EC were 73.33% and 76.67%, respectively; area under the ROC curve was 0.778 (95%CI 0.695–0.861). Transfection of miR-630 into EC cells indicated that miR-630 overexpression can reduce EC cell invasion and migration (p < 0.05). miR-630 expression is low in EC and has good diagnostic value for EC. Conclusion: miR-630 overexpression can reduce EC cell invasion and migration, showing a possible key role of miR-630 in EC diagnosis and treatment in the future. © 2021 The Authors. Journal of Clinical Laboratory Analysis published by Wiley Periodicals LLC 
650 0 4 |a adult 
650 0 4 |a apoptosis 
650 0 4 |a Apoptosis 
650 0 4 |a Article 
650 0 4 |a Biomarkers, Tumor 
650 0 4 |a blood level 
650 0 4 |a cancer prognosis 
650 0 4 |a cancer staging 
650 0 4 |a cancer survival 
650 0 4 |a case control study 
650 0 4 |a Case-Control Studies 
650 0 4 |a cell invasion 
650 0 4 |a cell migration 
650 0 4 |a cell motion 
650 0 4 |a Cell Movement 
650 0 4 |a cell proliferation 
650 0 4 |a Cell Proliferation 
650 0 4 |a comparative study 
650 0 4 |a controlled study 
650 0 4 |a diagnostic test accuracy study 
650 0 4 |a diagnostic value 
650 0 4 |a diagnostic value 
650 0 4 |a disease course 
650 0 4 |a esophageal cancer 
650 0 4 |a esophageal cancer cell line 
650 0 4 |a Esophageal Neoplasms 
650 0 4 |a esophagus cancer 
650 0 4 |a esophagus tumor 
650 0 4 |a female 
650 0 4 |a Female 
650 0 4 |a gene expression 
650 0 4 |a gene expression regulation 
650 0 4 |a Gene Expression Regulation, Neoplastic 
650 0 4 |a gene overexpression 
650 0 4 |a genetics 
650 0 4 |a hospital admission 
650 0 4 |a human 
650 0 4 |a human cell 
650 0 4 |a Humans 
650 0 4 |a invasion 
650 0 4 |a major clinical study 
650 0 4 |a male 
650 0 4 |a Male 
650 0 4 |a metabolism 
650 0 4 |a metastasis 
650 0 4 |a microRNA 
650 0 4 |a microRNA 
650 0 4 |a microRNA 630 
650 0 4 |a MicroRNAs 
650 0 4 |a middle aged 
650 0 4 |a Middle Aged 
650 0 4 |a migration 
650 0 4 |a miR-630 
650 0 4 |a MIRN630 microRNA, human 
650 0 4 |a Neoplasm Invasiveness 
650 0 4 |a pathology 
650 0 4 |a prognosis 
650 0 4 |a Prognosis 
650 0 4 |a sensitivity and specificity 
650 0 4 |a survival rate 
650 0 4 |a Survival Rate 
650 0 4 |a tumor cell culture 
650 0 4 |a Tumor Cells, Cultured 
650 0 4 |a tumor invasion 
650 0 4 |a tumor marker 
650 0 4 |a unclassified drug 
700 1 |a Liao, K.  |e author 
700 1 |a Liu, X.  |e author 
700 1 |a Qiu, Y.  |e author 
700 1 |a Tan, W.  |e author 
700 1 |a Wu, W.  |e author 
700 1 |a Yang, K.  |e author 
700 1 |a Zhang, S.  |e author 
773 |t Journal of Clinical Laboratory Analysis